gadolinium dtpa has been researched along with Genital Diseases, Female in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brix, G; Essig, M; Hawighorst, H; Hoffmann, U; Knapstein, PG; Knopp, MV; Schaeffer, U; van Kaick, G; Zuna, I | 1 |
Mitchell, DG; Outwater, EK; Siegelman, ES; Wilson, KM | 1 |
2 other study(ies) available for gadolinium dtpa and Genital Diseases, Female
Article | Year |
---|---|
Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium DTPA; Genital Diseases, Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Meglumine; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Organometallic Compounds; Pelvic Neoplasms; Pentetic Acid; Uterine Cervical Neoplasms | 1996 |
Benign and malignant gynecologic disease: clinical importance of fluid and peritoneal enhancement in the pelvis at MR imaging.
Topics: Ascitic Fluid; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Genital Diseases, Female; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Peritoneal Neoplasms; Peritoneum; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 1996 |